Literature DB >> 3401642

A study of the actions of P1-purinoceptor agonists and antagonists in the mouse vas deferens in vitro.

A G Blakeley1, P M Dunn, S A Petersen.   

Abstract

1. We have examined the effects of purinoceptor agonists and antagonists on the mechanical 'twitch' response, excitatory junction potential (e.j.p.) amplitude and [3H]-noradrenaline overflow in the mouse vas deferens. 2. The agonist profile for inhibition of the mechanical response was N6-([R]-2-phenylisopropyl)adenosine (L-PIA) congruent to N6-cyclohexyladenosine (CHA) greater than 5' N-ethylcarboxamido-adenosine (NECA) greater than 2-chloroadenosine (2ClA) congruent N6-([S]-2-phenylisopropyl)adenosine (D-PIA). 3. The P1-purinoceptor agonists inhibited the e.j.p. with an agonist profile of CHA greater than L-PIA congruent to NECA greater than 2ClA. 4. 2ClA inhibited [3H]-noradrenaline overflow with an EC50 of 1.2 microM which was not significantly different from the values for inhibition of the e.j.p. and the mechanical response. 5. The inhibitory action of 2ClA on the mechanical response was antagonized by 5 microM 8-phenyltheophylline (8-PT). However, neither blockade of P1-purinoceptors by 8-PT nor increasing the rate of degradation of endogenous adenosine by addition of adenosine deaminase had any effect on the mechanical response per se. 8-PT (5 microM) also failed to alter the e.j.p. amplitude or [3H]-noradrenaline overflow. 6. These results indicate that there are P1-purinoceptors present on sympathetic nerve terminals of the mouse vas deferens which are more like A1- than A2-receptors, but may be better classified as being of the A3-subtype (Ribeiro & Sebastiao, 1986). These receptors are not normally involved in the feedback regulation of transmitter release in this tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401642      PMCID: PMC1853933          DOI: 10.1111/j.1476-5381.1988.tb11497.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens.

Authors:  A S Clanachan; A Johns; D M Paton
Journal:  Neuroscience       Date:  1977       Impact factor: 3.590

Review 2.  Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor.

Authors:  J A Ribeiro; A M Sebastião
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

3.  Purinergic inhibition of adrenergic transmission in rabbit blood vessels.

Authors:  C Su
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

4.  The effects of release and depletion of endogenous noradrenaline on the transmission of impulses in the mouse vas deferens.

Authors:  I Marshall; P A Nasmyth; N B Shepperson
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

5.  Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture.

Authors:  R L MacDonald; J H Skerritt; M A Werz
Journal:  J Physiol       Date:  1986-01       Impact factor: 5.182

6.  The effects of adenosine on receptor sensitivity in the rat vas deferens.

Authors:  C J Long; T W Stone
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

7.  The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.

Authors:  B L Ginsborg; G D Hirst
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

8.  Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens.

Authors:  A G Blakeley; A Mathie; S A Petersen
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

9.  Possible feed-back inhibition of noradrenaline release by purine compounds.

Authors:  M A Enero; B Q Saidman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

10.  The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens.

Authors:  D P Westfall; R E Stitzel; J N Rowe
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

View more
  9 in total

1.  Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues.

Authors:  A U Trendelenburg; S L Cox; V Schelb; W Klebroff; L Khairallah; K Starke
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Individual sympathetic varicosities possess different sensitivities to alpha 2 and P2 receptor agonists and antagonists in mouse vas deferens.

Authors:  S C O'Connor; K L Brain; M R Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Post- and prejunctional consequences of ecto-ATPase inhibition: electrical and contractile studies in guinea-pig vas deferens.

Authors:  P Ghildyal; D Palani; R Manchanda
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

4.  Effects of A1-adenosine receptor antagonists on purinergic transmission in the guinea-pig vas deferens in vitro.

Authors:  T A Hardy; J A Brock
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Uptake inhibitors do not change the effect of imidazoline alpha 2-adrenoceptor agonists on transmitter release evoked by single pulse stimulation in mouse vas deferens.

Authors:  J Gonçalves; F Carvalho; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

6.  Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.

Authors:  I von Kügelgen; E Schöffel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

7.  Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.

Authors:  K Kurz; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

8.  Methoxamine inhibits noradrenaline release through activation of alpha 1- and alpha 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins.

Authors:  C Bohmann; P Schollmeyer; L C Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

9.  P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.

Authors:  B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.